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Abstract
Background: Migration and HIV infection are known risk factors for methicillin-resistant Staphylococcus 
aureus (MRSA) carriage and infection. The aim of the study was to analyze the prevalence of MRSA nasal 
colonization in a high risk population of HIV-negative migrants and HIV-infected subjects. Secondary aim 
was to investigate over time MRSA carriage prevalence in HIV-infected subjects.
Methods: During the study period (January-June 2008), nasal swabs were collected from 96 HIV-negative 
migrants and 63 HIV-infected patients. A group of 68 seropositive subjects was additionally screened for 
MRSA carriage in 2012. Subjects were evaluated for HIV status, previous antibiotic use or hospitalization, 
soft tissue and skin infections (SSI), nationality and work conditions. The swab specimens were plated and in-
cubated for 24-h under static condition at 37° and then identified as S. aureus by using standard methods.
Results: A total of 227 subjects, 131 HIV-infected adults (63 in 2008 and 68 in 2012) and 96 HIV-negative 
migrants, were analyzed. Overall, 71/227 (31.2%) were S. aureus carriers: 34 out of 131 (25.9%) among 
HIV infected subjects and 37 out of 96 (38.5%) among migrants. Two MRSA were detected in HIV-infected 
patients (2.8%). Between 2008 and 2012 there was an increase of MRSA carriage in HIV+ group (p=0.49). 
No statistically significant differences were found between S. aureus carriers and no-carriers in terms of 
CD4+ cell count, TMP/SMX prophylaxis, previous antibiotic use or hospitalization, nationality and duration 
of stay in Italy. Among HIV+ patients there was a higher prevalence of SSI in MSSA carriers compared with 
no carriers (25% vs 4%, p=0.028). In the migrants group, having a job based on a close human contact 
was significantly associated with S. aureus colonization (p=0.0038). 
Conclusions: Despite of the high prevalence of S. aureus isolation (31.2%), the present study showed the 
low rate of MRSA carriage in a high risk population. The main factor associated with S. aureus colonization 
was a close human contact rather than the HIV status and the condition of being migrant. 
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Introduction
Since its discovery in the second half 
of 1900s, methicillin-resistant S. aureus 
(MRSA) has been increasingly recog-
nized as an important pathogen both in 
healthcare and community settings (1, 
2). In recent years, community-acquired 
MRSA (CA-MRSA) has emerged as an 
threatening pathogen (3), causing out-
breaks in athletes (4), military personnel 
(5), native Americans (6), injection drug 
users (IDUs) (7) and men who have sex 
with men (MSM) (8), thus highlighting 
that the spread of CA-MRSA is facilitated 
by a close human-to-human contact. S. 
aureus colonization is a risk factor for 
infection: patients colonized with MRSA 
have a two-to-twelve-fold increase of de-
veloping subsequent MRSA infection (9). 
HIV has been recognized as an independ-
ent risk factor for MRSA colonization 
and infection (10). On the other hand, 
migration has been showed to promote the 
diffusion and the circulation of different 
clones of MRSA (11-13). 
In the present study, the prevalence 
and risk factors for MRSA colonization 
in a high risk population of HIV-infected 
subjects and migrants attending an am-
bulatory clinic in Rome was analyzed. 
Furthermore, it was investigated the 
temporal trend of MRSA carriage preva-
lence in HIV-infected subjects over time 
by comparing two different groups of 
subjects. 
Materials and methods
Study population
A retrospective study among 159 sub-
jects (63 adult HIV-infected subjects and 
96 HIV seronegative migrants) attending 
the outpatients clinic of the Department 
of Infectious and Tropical Diseases of 
Sapienza University of Rome between 
January and June 2008 was conducted. 
In addition, 68 seropositive subjects 
were screened for MRSA carriage in 
2012. Thus, a total of 227 patients were 
included in the study.
Overall, subjects were evaluated for 
HIV status, previous antibiotic use or 
hospitalization and presence of soft tissue 
and skin infections (SSI) at the time of 
swabs collection. Antibiotic use and hos-
pitalization were defined as antimicrobial 
assumption or hospital stay for any reason 
in the previous 6 and 12 months, respec-
tively. SSI included impetigo, erysipela 
and cellulitis.
HIV staging, risk factors for HIV 
infection, antiretroviral (ARV) therapy 
and trimetroprim/sulfametoxazole (TMP/
SMX) prophylaxis were evaluated for 
all HIV-infected subjects. For migrants, 
additional informations including nation-
ality, length of permanence in Italy and 
socio-economic status were collected. 
Furthermore, migrants were divided into 
two groups according to their working 
conditions: migrants having a job based 
on a close contact (baby-sitting, assist-
ance to old people) and migrants having 
a job without a close contact (house-
wives, restaurant workers). Unemployed 
subjects were included in the second 
group. “Close contact” was defined as 
job contact which was considered to be 
intimate human-to-human contact. The 
study was approved by the institutional 
review board (Section of Infectious Dis-
eases, Department of Public Health and 
Infectious Diseases, Sapienza University 
of Rome). All study participants gave 
informed written consent. 
Sample collection
Nasal swabs were obtained with a 
sterile polyester fiber-tipped swab that 
had been moistened with sterile saline 
(BBLTM Culture SwabTM Becton, Dick-
inson France). The swab specimens 
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obtained from the subjects’ anterior 
nares were plated on Mannitol salt agar 
(Chapman medium, Oxoid). After a 24-h 
incubation under static condition at 37°C, 
positive colonies from each sample were 
spread onto 5% sheep blood agar plates 
(Becton, Dickinson France), and a single 
colony was selected for additional analy-
sis. The golden haemolytic cultures were 
identified as S. aureus by means of the 
Staphyloslide agglutination test (Becton, 
Dickinson France) and by using the au-
tomated system VITEK-2 (Bio-Merieux, 
Marcy l’Etoile, France). Cultures posi-
tive for bacteria other than S. aureus, as 
coagulase negative staphylococci (CNS), 
were excluded from further analyses.
According to the guidelines issued by 
the Clinical and Laboratory Standards 
Institute (CLSI) (14), oxacillin resistance 
in S. aureus was evaluated by using either 
oxacillin disks (6μg/ml) or the cefoxitin 
screening method (Oxoid) in Mueller-
Hinton agar plates. The oxacillin-resistant 
strain were submitted to a full susceptibil-
ity test evaluation including gentamicin, 
erythromycin, glycopeptides, rifampin, 
TMP/SMX, fluoroquinolones, clyndam-
icin and linezolid. Antimicrobial sus-
ceptibility testing (AST) was performed 
using the VITEK-2 system (Bio-Merieux, 
Marcy l’Etoile, France). All samples 
reached the microbiology laboratory 
within 3 hours from the collection. 
Statistical analysis
Categorical variables were compared 
by using the X2 or Fisher’s exact test, 
as appropriate. Continuous data were 
analyzed with Student’s t-test whereas 
the non-parametric Mann-Whitney test 
was applied for values not normally 
distributed. A p-value <0.05 was consid-
ered statistically significant. Statistical 
analyses were performed using STATA 9 
software (STATA corp. LP, College Sta-
tion, Texas, USA).
Results
Characteristics of study population 
A total of 227 subjects were enrolled 
in the study, 131 HIV-infected adults (63 
in 2008 and 68 in 2012) and 96 HIV-
negative migrants. 93 were females, 134 
were males, with a mean age of 38.7+10.6 
years. Among HIV-infected subjects, 92 
(70.2%) were males and the mean age 
was 46.2±9 years. The virological and 
immunological status were as follows: 
mean CD4+ cell count was 493±144.2 
cell/mmc, mean viral load 130352 (range 
0-500000) cp/ml. 129 patients (98.4%) 
were on antiretroviral therapy, 21 (16%) 
had prophylaxis with TMP/SMX. Consid-
ering the single risk factors for HIV in-
fection, IDUs and MSM were 20 (15.2%) 
and 33 (25.2%), respectively. Six patients 
(4.5%) had SSIs at the time of swab col-
lection. The mean age of migrants was 
34+9.8 years (42 males, 54 females). The 
nationalities were the following: 37.5% 
from East Europe, 30.2% from Asian 
countries, 18.8% from Latin America 
and 13.5% from Africa. The mean length 
of stay in Italy was 4+2 years. 66 (69%) 
were employed, with 37 (38.5%) having 
a job based on a close human-to-human 
contact. Previous antibiotic therapy and/
or hospitalization were present in 20 
(15.2%) and 41 (42.7%) of HIV-positive 
patients and migrants, respectively. 
S. aureus carriage
Overall, microbiological analyses 
showed that 71/227 (31.2%) of the sub-
jects were nasal S. aureus carriers: 34 
out of 131 (25.9%) among HIV-infected 
subjects and 37 out of 96 (38.5%) among 
migrants. Among all S. aureus isolates, 
only 2 MRSA were detected (2.8%) 
(Figure 1). 
All methicillin-susceptible S. aureus 
(MSSA) isolates were sensitive to linezol-
id, glycopeptides, rifampin, gentamicin, 
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erythromycin whereas 73.5% were re-
sistant to penicillin, 3% to TMP/SMX, 
fluoroquinolones and tetracycline; 8.8% 
showed less sensitivity to clyndamicin. 
One single strain resulted resistant to 
trimethoprim/sulfamethoxazole, fluoro-
quinolones, tetracycline and clyndamicin. 
MRSA strains were sensitive to rifampin, 
linezolid, glycopeptides, resistant to tri-
methoprim/sulfamethoxazole, fluoroqui-
nolones, erythromycin and clyndamicin.
No statistically differences were found 
between MSSA carriers and no-carriers in 
terms of sex and age. Previous antibiotic 
use or hospitalization did not significantly 
affect total carriage rates.
HIV-infected subjects screened in 2008
The rate of nasal S. aureus carriage 
was 25.4% (16/63). No MRSA was de-
tected (Figure 1). The immunological 
and virological status, as well as TMP/
SMX prophylaxis, did not significantly 
affect nasal carriage rates. Although 
the percentage of IDUs and MSM was 
higher in HIV+ carriers compared with 
HIV+ no-carriers (12% vs 9% and 37% 
vs 16%, respectively) this difference was 
not statistically significant (p = 0.63; p = 
0.16). In contrast, there was a significant 
higher prevalence of SSI in MSSA car-
riers compared with no carriers (25% vs 
4%, p = 0.028) (Table 1).
HIV-negative migrants
S. aureus was detected in 37 out of 96 
(38.5%) migrants. No MRSA grew (Figu-
re 1). Among all the considered factors, 
there were no differences in terms of sex, 
age and median length of permanence in 
Italy between MSSA+ and MSSA- mi-
grants. Interestingly, nationality did not 
significantly affect the colonization rate. 
21 (57%) subjects who had a job based 
Figure 1 - S. aureus nasal colonization in the study popu-
lation. During the study period, there was an increase of 
MRSA in HIV-infected subjects (0% vs 2.9%). Values 
are expressed as percentage. 
Table 1 - S. aureus nasal colonization prevalence in HIV-infected subjects 
S. aureus
carriers
(N: 16)
S. aureus
non-carriers
(N: 47)
p-value
Age, yr (mean ± SD) 47±9.7 46.6±9.7 0.9
Males, no. (%)
Females, no. (%)
11 (68.7%)
5 (31.3%)
28 (59.5%)
19 (49.5%)
0.56
Risk factor for HIV infection
   MSM, no. (%)
   IDUs, no. (%)
6 (37.5%)
2 (12.5%)
8 (17%)
4 (8.5%)
0.16
0.63
Viro-immunological status
   CD4+, cell/mmc (mean ± SD)
   HIV-RNA, cp/ml (mean ± SD)
468 ± 93
5625 ± 2470
360 ± 64
24989 ± 1900
0.2
0.3
SSI, no. (%) 4 (25%) 2 (4%) 0.028
TMP/SMX prophylaxis, no. (%) 4 (25%) 15 (31%) 0.18
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on a close contact were more frequently 
MSSA carriers, in comparison to 16 
(27.1%) subjects who did not have a job 
with human contact (p = 0.0038). Mi-
grants living with the employer showed 
a higher rate of S. aureus carriage when 
compared with those living with their fa-
mily or subjects with the same nationality 
(57.9% vs 33.8%, respectively; p = 0.06) 
(Table 2).
HIV-infected subjects screened in 2012.
A total of 68 HIV-infected subject 
was screened for MRSA nasal carriage 
in 2012. The demographic characteristics 
and the presence of risk factors for HIV 
infection were similar to those of the 
previous group of HIV-infected patients. 
Mean CD4+ cell count was 595+131 cell/
mmc whereas the HIV-RNA was detec-
table in only 3/68 (4.4%) subjects. The 
majority of patients (67/68, 98.5%) were 
on antiretroviral therapy, 2 (2.9%) had 
prophylaxis with TMP/SMX. Previous 
antibiotic therapy and/or hospitalization 
were present in 3 (4.4%) of the patients. 
Overall,  16/68 were MSSA carriers 
(23.5%). In contrast with the lack of 
MRSA carriage previously observed, 
2 out of 68 (2.97%) were positive for 
MRSA. However, this increase was not 
statistically significant (p = 0.49) (Figure 
1). No association between HIV staging, 
risk factors, presence of SSI at the mo-
ment of sample collection and MRSA 
colonization was found. 
Discussion
MRSA infections are a major threat 
worldwide (15). S. aureus colonization is 
Table 2 - S. aureus nasal colonization prevalence in HIV-negative migrants.
S. aureus
carriers
(N: 37)
S. aureus
non-carriers
(N: 59)
p-value
Age, yr, no. (%)
   < 30 yr
   30-49yr
   > 49yr
16 (43.2%)
10 (27%)
11 (29.8%)
17 (28.8%)
21 (35.6%)
21 (35.6%)
0.18
Males, no. (%)
Females, no. (%)
16 (43.2%)
21 (56.8%)
26 (44.1%)
33 (55.9%)
0.56
Lenght of stay in Italy, no. (%)
   ≤ 5 years
   > 5 years
28 (75.7%)
9 (24.3%)
48 (81.4%)
11 (18.6%)
0.52
Nationality, no. (%)
   Africa
   Asia
   East-Europe
   Latin America
6 (15.8%)
11 (30%)
14 (38%)
6 (16.2%)
7 (11.8%)
17 (28.9%)
23 (39%)
12 (20.3%)
0.55
Living conditions, no. (%)
   same nationality/family
   with employer 
26 (70.3%)
11 (29.7%)
51 (86.4%)
8.(13.6%)
0.06
Working conditions, no. (%)*
   Job with close contact
   Job without close contact
21 (61.8%)
13 (38.2%)
16 (29.1%)
39 (70.9%)
0.0038
* Missing data due to linguistic difficulties with migrants.
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a predominant risk factor for subsequent 
infection: MRSA infection is 4 times 
more frequent in MRSA carriers than in 
noncarriers (16).The principal reservoir 
of S. aureus is the nasopharynx (17), al-
though several studies identified throat, 
arm pit, perineum and gastrointestinal 
tract as other possible sites of S. aureus 
carriage (18, 19). The occurrence of CA-
MRSA outbreaks in athletes, military 
personnel, IDUs, MSM and prisoners 
supports the hypothesis that the acquisi-
tion and the spread of this strain need a 
close human-to-human contact. 
Despite a high rate of infections due to 
MRSA (20), Italy is one of the European 
countries where the prevalence of MRSA 
carriage is low (21, 22). Current guide-
lines for MRSA prevention and control 
(23) highlight the importance of control-
ling MRSA spread by early recognition 
of colonized patients, especially in high 
risk populations. 
HIV-positive subjects have a higher 
rate of S. aureus colonization than general 
population (24). The strong association 
between HIV infection and S. aureus 
colonization could explain the greater 
incidence of infections due to MRSA in 
this population (25). Despite the reasons 
for the association between HIV infection 
and S. aureus remain unknown, environ-
mental factors and the immunologic HIV-
related abnormalities could play a patho-
genetic role (25). Behavioral risk factors 
(i.e. MSM, IDUs) and the immunological 
status with a low CD4+ cell count have 
been associated with MRSA colonization 
(25). In contrast, the use of TMP/SMX as 
a prophylaxis appeared to be protective 
(24). Our study confirmed the high rate of 
S. aureus nasal carriage in HIV-infected 
subjects (25.9%). A significant asso-
ciation between MSSA carriers and the 
presence of SSIs at the moment of sample 
collection was found, thus suggesting 
the importance of skin-to-skin contact in 
determining both colonization and infec-
tion. In contrast with other studies (24, 
25) , immunological status did not cor-
relate with colonization. Instead, a study 
conducted by Miller et al (26) showed 
that CD4+ cell count was not associated 
with prevalent, incident or persistent S. 
aureus carriage. Overall, we found a low 
prevalence of MRSA nasal colonization. 
However, when the study population was 
stratified according to the different years 
of sample collection, we showed that the 
detection of MRSA rose up to 2.9% in 
2012 compared with the lack of MRSA 
detection in 2008. Although not statisti-
cally significant (p=0.49), this finding 
highlights that HIV-infected subjects are 
at risk of MRSA nasal colonization. 
Migration is another known risk factor 
for MRSA carriage. In fact, in countries 
with a low MRSA prevalence, transmis-
sion of imported cases of MRSA is one of 
the crucial risk factors that influence the 
risk for MRSA acquisition (27). Studies 
conducted in Sweden and Norway among 
foreign children demonstrated an intra-fa-
miliar transmission of methicillin-resist-
ant clones from adopted children coming 
from countries where MRSA was highly 
prevalent (12, 13). Furthermore, a Span-
ish study showed that among CA-MRSA 
carriers, most of them were immigrants 
(28) and a Danish study highlighted that 
non-Danish origin was the only independ-
ent risk factor associated with CA-MRSA 
infections (29). These results strongly 
suggest that the increase of the migratory 
flows in the world could contribute to the 
spread of MRSA, even in countries where 
the prevalence of MRSA is still low. In 
the present study, despite the absence of 
MRSA detection, we found a high rate of 
S. aureus nasal carriage among migrants 
(38.5%). The main factor associated with 
S. aureus colonization was close human-
to-human contact (i.e. work conditions). 
These findings highlight how important 
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is the human contact for the spread of S. 
aureus strains. Moreover, we found that 
migrants who lived with the employers 
were S. aureus carriers more frequently 
than migrants who lived together or with 
their family, thus suggesting that not only 
migrants could favour the spread of S. 
aureus clones, but also living with Italian 
people could expose migrants to the risk 
of being colonized.
In conclusion, despite the high preva-
lence of S. aureus isolation (31.2%), 
the study showed a low detection rate 
of MRSA nasal carriage in a high risk 
population of HIV-infected subjects and 
migrants. The main factor associated with 
S. aureus colonization was a close human-
to-human contact rather than HIV status 
and the condition of being migrant. 
Riassunto
Studio della colonizzazione nasale da Staphylococcus 
aureus meticillino-resistente (MRSA) in una popola-
zione di immigrati HIV-negativi e soggetti HIV-positivi 
in un ambulatorio di Roma 
Background: La migrazione e l’infezione da HIV 
sono fattori di rischio sia per la colonizzazione che 
per l’infezione da Staphylococcus aureus meticillino-
resistente (MRSA). Scopo dello studio è stato quello di 
analizzare la prevalenza della colonizzazione nasale da 
MRSA in una popolazione ad elevato rischio di pazienti 
HIV-positivi e immigrati HIV-negativi. Inoltre, è stata 
analizzata nel tempo la prevalenza della colonizzazione 
da MRSA nei soggetti HIV-positivi.
Metodi: Durante il periodo dello studio (Gennaio-
Giugno 2008), sono stati effettuati tamponi nasali in 
96 immigrati HIV-negativi e 63 soggetti HIV-positivi. 
Un addizionale gruppo di 68 pazienti con infezione da 
HIV è stato analizzato per colonizzazione da MRSA 
nel 2012. Per ciascun soggetto sono stati considerati: 
la presenza di infezione da HIV, una precedente terapia 
antibiotica o un precedente ricovero, la presenza di in-
fezione della cute e dei tessuti molli al momento della 
raccolta del campione, la nazionalità e le condizioni di 
lavoro. I campioni raccolti sono stati incubati a 37° per 
24h e i microorganismi identificati secondo le tecniche 
microbiologiche standard.
Risultati: Un totale di 227 pazienti, 131 adulti con 
infezione da HIV (63 nel 2008 e 68 nel 2012) e 96 
immigrati HIV-negativi sono stati inclusi nello studio. 
Globalmente, 71/227 (31.2%) erano colonizzati da S. au-
reus: 34/131 (25.9%) tra gli HIV-positivi, 37/96 (38.5%) 
tra gli immigrati. Solo 2 MRSA sono stati identificati, nel 
gruppo dei soggetti con infezione da HIV. Nel periodo tra 
il 2008 e il 2012, è stato notato un incremento della colo-
nizzazione nasale da MRSA all’interno dei pazienti HIV-
positvi: dallo 0% del 2008 al 2.8% del 2012 (p=0.49). 
Tra i soggetti colonizzati e quelli non colonizzati, non 
sono state trovate differenze statisticamente significative 
in termini di status viro-immunologico, precedenti rico-
veri o terapie antibiotiche, nazionalità e, per gli stranieri, 
durata della permanenza in Italia. Tra gli HIV-positivi, è 
stata trovata una maggiore prevalenza di infezioni della 
cute e dei tessuti molli nei colonizzati rispetto ai non 
colonizzati (25% vs 4%, p=0.028). Nel gruppo degli 
immigrati, avere un lavoro che presupponeva uno stretto 
contatto umano risultava statisticamente associato alla 
colonizzazione da S. aureus (p=0.0038). 
Conclusioni: Nonostante una elevata prevalenza di 
isolamento di S. aureus (31.2%), il presente studio di-
mostra il basso tasso di colonizzazione da MRSA in una 
popolazione considerata ad alto rischio. Il principale fat-
tore associato alla colonizzazione da S. aureus è risultato 
essere il contatto interumano piuttosto che la presenza 
dell’ infezione da HIV o la condizione di migrante.
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